Global Antisense Oligonucleotides (ASOs) Drugs Supply, Demand and Key Producers, 2024-2030

Page: 111

Published Date: 21 May 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).

The global Antisense Oligonucleotides (ASOs) Drugs market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Antisense Oligonucleotides (ASOs) Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotides (ASOs) Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotides (ASOs) Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Antisense Oligonucleotides (ASOs) Drugs total production and demand, 2019-2030, (K Units)
Global Antisense Oligonucleotides (ASOs) Drugs total production value, 2019-2030, (USD Million)
Global Antisense Oligonucleotides (ASOs) Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Antisense Oligonucleotides (ASOs) Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Antisense Oligonucleotides (ASOs) Drugs domestic production, consumption, key domestic manufacturers and share
Global Antisense Oligonucleotides (ASOs) Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Antisense Oligonucleotides (ASOs) Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Antisense Oligonucleotides (ASOs) Drugs production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Antisense Oligonucleotides (ASOs) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonis Pharmaceuticals, Novartis, Sanofi, GSK, Sarepta, Kastle, Biogen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense Oligonucleotides (ASOs) Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Antisense Oligonucleotides (ASOs) Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Antisense Oligonucleotides (ASOs) Drugs Market, Segmentation by Type:
    Cleave and Degrade
    Splice

Global Antisense Oligonucleotides (ASOs) Drugs Market, Segmentation by Application:
    Hospital
    Clinic

Companies Profiled:
    Lonis Pharmaceuticals
    Novartis
    Sanofi
    GSK
    Sarepta
    Kastle
    Biogen

Key Questions Answered:
1. How big is the global Antisense Oligonucleotides (ASOs) Drugs market?
2. What is the demand of the global Antisense Oligonucleotides (ASOs) Drugs market?
3. What is the year over year growth of the global Antisense Oligonucleotides (ASOs) Drugs market?
4. What is the production and production value of the global Antisense Oligonucleotides (ASOs) Drugs market?
5. Who are the key producers in the global Antisense Oligonucleotides (ASOs) Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Antisense Oligonucleotides (ASOs) Drugs Introduction
    1.2 World Antisense Oligonucleotides (ASOs) Drugs Supply & Forecast
        1.2.1 World Antisense Oligonucleotides (ASOs) Drugs Production Value (2019 & 2023 & 2030)
        1.2.2 World Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030)
        1.2.3 World Antisense Oligonucleotides (ASOs) Drugs Pricing Trends (2019-2030)
    1.3 World Antisense Oligonucleotides (ASOs) Drugs Production by Region (Based on Production Site)
        1.3.1 World Antisense Oligonucleotides (ASOs) Drugs Production Value by Region (2019-2030)
        1.3.2 World Antisense Oligonucleotides (ASOs) Drugs Production by Region (2019-2030)
        1.3.3 World Antisense Oligonucleotides (ASOs) Drugs Average Price by Region (2019-2030)
        1.3.4 North America Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030)
        1.3.5 Europe Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030)
        1.3.6 China Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030)
        1.3.7 Japan Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Antisense Oligonucleotides (ASOs) Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Antisense Oligonucleotides (ASOs) Drugs Major Market Trends

2 Demand Summary
    2.1 World Antisense Oligonucleotides (ASOs) Drugs Demand (2019-2030)
    2.2 World Antisense Oligonucleotides (ASOs) Drugs Consumption by Region
        2.2.1 World Antisense Oligonucleotides (ASOs) Drugs Consumption by Region (2019-2024)
        2.2.2 World Antisense Oligonucleotides (ASOs) Drugs Consumption Forecast by Region (2025-2030)
    2.3 United States Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030)
    2.4 China Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030)
    2.5 Europe Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030)
    2.6 Japan Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030)
    2.7 South Korea Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030)
    2.8 ASEAN Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030)
    2.9 India Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Antisense Oligonucleotides (ASOs) Drugs Production Value by Manufacturer (2019-2024)
    3.2 World Antisense Oligonucleotides (ASOs) Drugs Production by Manufacturer (2019-2024)
    3.3 World Antisense Oligonucleotides (ASOs) Drugs Average Price by Manufacturer (2019-2024)
    3.4 Antisense Oligonucleotides (ASOs) Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Antisense Oligonucleotides (ASOs) Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotides (ASOs) Drugs in 2023
        3.5.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotides (ASOs) Drugs in 2023
    3.6 Antisense Oligonucleotides (ASOs) Drugs Market: Overall Company Footprint Analysis
        3.6.1 Antisense Oligonucleotides (ASOs) Drugs Market: Region Footprint
        3.6.2 Antisense Oligonucleotides (ASOs) Drugs Market: Company Product Type Footprint
        3.6.3 Antisense Oligonucleotides (ASOs) Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Production Value Comparison
        4.1.1 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Production Comparison
        4.2.1 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Consumption Comparison
        4.3.1 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Antisense Oligonucleotides (ASOs) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production (2019-2024)
    4.5 China Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers and Market Share
        4.5.1 China Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value (2019-2024)
        4.5.3 China Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production (2019-2024)
    4.6 Rest of World Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production (2019-2024)

5 Market Analysis by Type
    5.1 World Antisense Oligonucleotides (ASOs) Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Cleave and Degrade
        5.2.2 Splice
    5.3 Market Segment by Type
        5.3.1 World Antisense Oligonucleotides (ASOs) Drugs Production by Type (2019-2030)
        5.3.2 World Antisense Oligonucleotides (ASOs) Drugs Production Value by Type (2019-2030)
        5.3.3 World Antisense Oligonucleotides (ASOs) Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Antisense Oligonucleotides (ASOs) Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
    6.3 Market Segment by Application
        6.3.1 World Antisense Oligonucleotides (ASOs) Drugs Production by Application (2019-2030)
        6.3.2 World Antisense Oligonucleotides (ASOs) Drugs Production Value by Application (2019-2030)
        6.3.3 World Antisense Oligonucleotides (ASOs) Drugs Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Lonis Pharmaceuticals
        7.1.1 Lonis Pharmaceuticals Details
        7.1.2 Lonis Pharmaceuticals Major Business
        7.1.3 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product and Services
        7.1.4 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Lonis Pharmaceuticals Recent Developments/Updates
        7.1.6 Lonis Pharmaceuticals Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Antisense Oligonucleotides (ASOs) Drugs Product and Services
        7.2.4 Novartis Antisense Oligonucleotides (ASOs) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Sanofi
        7.3.1 Sanofi Details
        7.3.2 Sanofi Major Business
        7.3.3 Sanofi Antisense Oligonucleotides (ASOs) Drugs Product and Services
        7.3.4 Sanofi Antisense Oligonucleotides (ASOs) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Sanofi Recent Developments/Updates
        7.3.6 Sanofi Competitive Strengths & Weaknesses
    7.4 GSK
        7.4.1 GSK Details
        7.4.2 GSK Major Business
        7.4.3 GSK Antisense Oligonucleotides (ASOs) Drugs Product and Services
        7.4.4 GSK Antisense Oligonucleotides (ASOs) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 GSK Recent Developments/Updates
        7.4.6 GSK Competitive Strengths & Weaknesses
    7.5 Sarepta
        7.5.1 Sarepta Details
        7.5.2 Sarepta Major Business
        7.5.3 Sarepta Antisense Oligonucleotides (ASOs) Drugs Product and Services
        7.5.4 Sarepta Antisense Oligonucleotides (ASOs) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Sarepta Recent Developments/Updates
        7.5.6 Sarepta Competitive Strengths & Weaknesses
    7.6 Kastle
        7.6.1 Kastle Details
        7.6.2 Kastle Major Business
        7.6.3 Kastle Antisense Oligonucleotides (ASOs) Drugs Product and Services
        7.6.4 Kastle Antisense Oligonucleotides (ASOs) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Kastle Recent Developments/Updates
        7.6.6 Kastle Competitive Strengths & Weaknesses
    7.7 Biogen
        7.7.1 Biogen Details
        7.7.2 Biogen Major Business
        7.7.3 Biogen Antisense Oligonucleotides (ASOs) Drugs Product and Services
        7.7.4 Biogen Antisense Oligonucleotides (ASOs) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Biogen Recent Developments/Updates
        7.7.6 Biogen Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Antisense Oligonucleotides (ASOs) Drugs Industry Chain
    8.2 Antisense Oligonucleotides (ASOs) Drugs Upstream Analysis
        8.2.1 Antisense Oligonucleotides (ASOs) Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Antisense Oligonucleotides (ASOs) Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Antisense Oligonucleotides (ASOs) Drugs Production Mode
    8.6 Antisense Oligonucleotides (ASOs) Drugs Procurement Model
    8.7 Antisense Oligonucleotides (ASOs) Drugs Industry Sales Model and Sales Channels
        8.7.1 Antisense Oligonucleotides (ASOs) Drugs Sales Model
        8.7.2 Antisense Oligonucleotides (ASOs) Drugs Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share by Region (2019-2024)
 Table 5. World Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share by Region (2025-2030)
 Table 6. World Antisense Oligonucleotides (ASOs) Drugs Production by Region (2019-2024) & (K Units)
 Table 7. World Antisense Oligonucleotides (ASOs) Drugs Production by Region (2025-2030) & (K Units)
 Table 8. World Antisense Oligonucleotides (ASOs) Drugs Production Market Share by Region (2019-2024)
 Table 9. World Antisense Oligonucleotides (ASOs) Drugs Production Market Share by Region (2025-2030)
 Table 10. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Antisense Oligonucleotides (ASOs) Drugs Major Market Trends
 Table 13. World Antisense Oligonucleotides (ASOs) Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Antisense Oligonucleotides (ASOs) Drugs Consumption by Region (2019-2024) & (K Units)
 Table 15. World Antisense Oligonucleotides (ASOs) Drugs Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Antisense Oligonucleotides (ASOs) Drugs Producers in 2023
 Table 18. World Antisense Oligonucleotides (ASOs) Drugs Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Antisense Oligonucleotides (ASOs) Drugs Producers in 2023
 Table 20. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Antisense Oligonucleotides (ASOs) Drugs Company Evaluation Quadrant
 Table 22. World Antisense Oligonucleotides (ASOs) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Antisense Oligonucleotides (ASOs) Drugs Production Site of Key Manufacturer
 Table 24. Antisense Oligonucleotides (ASOs) Drugs Market: Company Product Type Footprint
 Table 25. Antisense Oligonucleotides (ASOs) Drugs Market: Company Product Application Footprint
 Table 26. Antisense Oligonucleotides (ASOs) Drugs Competitive Factors
 Table 27. Antisense Oligonucleotides (ASOs) Drugs New Entrant and Capacity Expansion Plans
 Table 28. Antisense Oligonucleotides (ASOs) Drugs Mergers & Acquisitions Activity
 Table 29. United States VS China Antisense Oligonucleotides (ASOs) Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Antisense Oligonucleotides (ASOs) Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Antisense Oligonucleotides (ASOs) Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Market Share (2019-2024)
 Table 37. China Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Market Share (2019-2024)
 Table 42. Rest of World Based Antisense Oligonucleotides (ASOs) Drugs Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Market Share (2019-2024)
 Table 47. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Antisense Oligonucleotides (ASOs) Drugs Production by Type (2019-2024) & (K Units)
 Table 49. World Antisense Oligonucleotides (ASOs) Drugs Production by Type (2025-2030) & (K Units)
 Table 50. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Antisense Oligonucleotides (ASOs) Drugs Production by Application (2019-2024) & (K Units)
 Table 56. World Antisense Oligonucleotides (ASOs) Drugs Production by Application (2025-2030) & (K Units)
 Table 57. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Lonis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 62. Lonis Pharmaceuticals Major Business
 Table 63. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 64. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Lonis Pharmaceuticals Recent Developments/Updates
 Table 66. Lonis Pharmaceuticals Competitive Strengths & Weaknesses
 Table 67. Novartis Basic Information, Manufacturing Base and Competitors
 Table 68. Novartis Major Business
 Table 69. Novartis Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 70. Novartis Antisense Oligonucleotides (ASOs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Novartis Recent Developments/Updates
 Table 72. Novartis Competitive Strengths & Weaknesses
 Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 74. Sanofi Major Business
 Table 75. Sanofi Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 76. Sanofi Antisense Oligonucleotides (ASOs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Sanofi Recent Developments/Updates
 Table 78. Sanofi Competitive Strengths & Weaknesses
 Table 79. GSK Basic Information, Manufacturing Base and Competitors
 Table 80. GSK Major Business
 Table 81. GSK Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 82. GSK Antisense Oligonucleotides (ASOs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. GSK Recent Developments/Updates
 Table 84. GSK Competitive Strengths & Weaknesses
 Table 85. Sarepta Basic Information, Manufacturing Base and Competitors
 Table 86. Sarepta Major Business
 Table 87. Sarepta Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 88. Sarepta Antisense Oligonucleotides (ASOs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Sarepta Recent Developments/Updates
 Table 90. Sarepta Competitive Strengths & Weaknesses
 Table 91. Kastle Basic Information, Manufacturing Base and Competitors
 Table 92. Kastle Major Business
 Table 93. Kastle Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 94. Kastle Antisense Oligonucleotides (ASOs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Kastle Recent Developments/Updates
 Table 96. Kastle Competitive Strengths & Weaknesses
 Table 97. Biogen Basic Information, Manufacturing Base and Competitors
 Table 98. Biogen Major Business
 Table 99. Biogen Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 100. Biogen Antisense Oligonucleotides (ASOs) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Biogen Recent Developments/Updates
 Table 102. Biogen Competitive Strengths & Weaknesses
 Table 103. Global Key Players of Antisense Oligonucleotides (ASOs) Drugs Upstream (Raw Materials)
 Table 104. Global Antisense Oligonucleotides (ASOs) Drugs Typical Customers
 Table 105. Antisense Oligonucleotides (ASOs) Drugs Typical Distributors


List of Figures
 Figure 1. Antisense Oligonucleotides (ASOs) Drugs Picture
 Figure 2. World Antisense Oligonucleotides (ASOs) Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Antisense Oligonucleotides (ASOs) Drugs Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030) & (K Units)
 Figure 5. World Antisense Oligonucleotides (ASOs) Drugs Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share by Region (2019-2030)
 Figure 7. World Antisense Oligonucleotides (ASOs) Drugs Production Market Share by Region (2019-2030)
 Figure 8. North America Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030) & (K Units)
 Figure 9. Europe Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030) & (K Units)
 Figure 10. China Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030) & (K Units)
 Figure 11. Japan Antisense Oligonucleotides (ASOs) Drugs Production (2019-2030) & (K Units)
 Figure 12. Antisense Oligonucleotides (ASOs) Drugs Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030) & (K Units)
 Figure 15. World Antisense Oligonucleotides (ASOs) Drugs Consumption Market Share by Region (2019-2030)
 Figure 16. United States Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030) & (K Units)
 Figure 17. China Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030) & (K Units)
 Figure 18. Europe Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030) & (K Units)
 Figure 19. Japan Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030) & (K Units)
 Figure 22. India Antisense Oligonucleotides (ASOs) Drugs Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Antisense Oligonucleotides (ASOs) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotides (ASOs) Drugs Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotides (ASOs) Drugs Markets in 2023
 Figure 26. United States VS China: Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Antisense Oligonucleotides (ASOs) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Antisense Oligonucleotides (ASOs) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Market Share 2023
 Figure 30. China Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Antisense Oligonucleotides (ASOs) Drugs Production Market Share 2023
 Figure 32. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share by Type in 2023
 Figure 34. Cleave and Degrade
 Figure 35. Splice
 Figure 36. World Antisense Oligonucleotides (ASOs) Drugs Production Market Share by Type (2019-2030)
 Figure 37. World Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share by Type (2019-2030)
 Figure 38. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Type (2019-2030) & (US$/Unit)
 Figure 39. World Antisense Oligonucleotides (ASOs) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share by Application in 2023
 Figure 41. Hospital
 Figure 42. Clinic
 Figure 43. World Antisense Oligonucleotides (ASOs) Drugs Production Market Share by Application (2019-2030)
 Figure 44. World Antisense Oligonucleotides (ASOs) Drugs Production Value Market Share by Application (2019-2030)
 Figure 45. World Antisense Oligonucleotides (ASOs) Drugs Average Price by Application (2019-2030) & (US$/Unit)
 Figure 46. Antisense Oligonucleotides (ASOs) Drugs Industry Chain
 Figure 47. Antisense Oligonucleotides (ASOs) Drugs Procurement Model
 Figure 48. Antisense Oligonucleotides (ASOs) Drugs Sales Model
 Figure 49. Antisense Oligonucleotides (ASOs) Drugs Sales Channels, Direct Sales, and Distribution
 Figure 50. Methodology
 Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lonis Pharmaceuticals
Novartis
Sanofi
GSK
Sarepta
Kastle
Biogen

Related Reports

Global Antisense Oligonucleotides (ASOs) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Antisense Oligonucleotides (ASOs) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 21 May 2024

date Pharma & Healthcare

Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).

Product Tags

Antisense Oligonucleotides (ASOs) Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>